73911000001102: Madopar 62.5 capsules (Roche Products Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Madopar 62.5 capsules (Roche Products Ltd)
• \UK product\Virtual medicinal product\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \UK product\Virtual therapeutic moiety\Co-beneldopa\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \UK product\Trade family\Madopar\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing benserazide\Product containing benserazide and levodopa\Co-beneldopa\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing benserazide\Product containing benserazide and levodopa\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing benserazide\Product containing benserazide and levodopa\Product containing only benserazide and levodopa (medicinal product)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing levodopa in oral dose form (medicinal product form)\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing benserazide and levodopa\Co-beneldopa\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing benserazide and levodopa\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing benserazide and levodopa\Product containing only benserazide and levodopa (medicinal product)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing levodopa in oral dose form (medicinal product form)\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing benserazide and levodopa\Co-beneldopa\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing benserazide and levodopa\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing benserazide and levodopa\Product containing only benserazide and levodopa (medicinal product)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing benserazide\Product containing benserazide and levodopa\Co-beneldopa\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing benserazide\Product containing benserazide and levodopa\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing benserazide\Product containing benserazide and levodopa\Product containing only benserazide and levodopa (medicinal product)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing benserazide\Product containing benserazide and levodopa\Co-beneldopa\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing benserazide\Product containing benserazide and levodopa\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing benserazide\Product containing benserazide and levodopa\Product containing only benserazide and levodopa (medicinal product)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing levodopa in oral dose form (medicinal product form)\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing benserazide and levodopa\Co-beneldopa\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing benserazide and levodopa\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing benserazide and levodopa\Product containing only benserazide and levodopa (medicinal product)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing levodopa in oral dose form (medicinal product form)\Product containing benserazide and levodopa in oral dose form (medicinal product form)\Product containing only benserazide and levodopa in oral dose form (medicinal product form)\Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)\Madopar 62.5 capsules (Roche Products Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
16701101000001113	Madopar 62.5 capsules (Roche Products Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
37706801000001110	Madopar 50mg/12.5mg capsules (Roche Products Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start